View Future GrowthEC Healthcare 과거 순이익 실적과거 기준 점검 0/6EC Healthcare 의 수입은 연평균 -56.6%의 비율로 감소해 온 반면, Consumer Services 산업은 연평균 25.1%의 비율로 증가했습니다. 매출은 연평균 18.3%의 비율로 증가해 왔습니다.핵심 정보-56.61%순이익 성장률-58.33%주당순이익(EPS) 성장률Consumer Services 산업 성장률20.27%매출 성장률18.26%자기자본이익률-5.08%순이익률-4.04%최근 순이익 업데이트31 Mar 2025최근 과거 실적 업데이트공고 • Jun 17EC Healthcare to Report Fiscal Year 2026 Final Results on Jun 29, 2026EC Healthcare announced that they will report fiscal year 2026 final results at 9:30 AM, China Standard Time on Jun 29, 2026공고 • Nov 17EC Healthcare to Report First Half, 2026 Results on Nov 28, 2025EC Healthcare announced that they will report first half, 2026 results on Nov 28, 2025공고 • Jun 09EC Healthcare to Report Fiscal Year 2025 Results on Jun 19, 2025EC Healthcare announced that they will report fiscal year 2025 results on Jun 19, 2025공고 • Nov 09EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024EC Healthcare announced that they will report first half, 2025 results on Nov 28, 2024공고 • Jun 15EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024EC Healthcare announced that they will report fiscal year 2024 results on Jun 27, 2024공고 • Nov 17EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023EC Healthcare announced that they will report first half, 2024 results on Nov 30, 2023모든 업데이트 보기Recent updates공고 • Jun 29EC Healthcare, Annual General Meeting, Aug 21, 2026EC Healthcare, Annual General Meeting, Aug 21, 2026.공고 • Jun 17EC Healthcare to Report Fiscal Year 2026 Final Results on Jun 29, 2026EC Healthcare announced that they will report fiscal year 2026 final results at 9:30 AM, China Standard Time on Jun 29, 2026공고 • Nov 28EC Healthcare Declares No Dividend for the Six Months Ended September 20, 2025EC Healthcare declared no dividend for the six months ended September 20, 2025 (2024: 1.0 HK Cents).공고 • Nov 17EC Healthcare to Report First Half, 2026 Results on Nov 28, 2025EC Healthcare announced that they will report first half, 2026 results on Nov 28, 2025공고 • Jun 23EC Healthcare Announces Appointment of Member of the Nomination CommitteeThe board of directors of EC Healthcare announced that Mrs. Leung Yang, Shih Ti Marianne, a non-executive director of the Company and Mr. Ma Ching Nam, an independent non-executive director of the Company, have been appointed as the members of the nomination committee under the Company with effect from 23 June 2025.공고 • Jun 19EC Healthcare, Annual General Meeting, Aug 22, 2025EC Healthcare, Annual General Meeting, Aug 22, 2025.공고 • Jun 09EC Healthcare to Report Fiscal Year 2025 Results on Jun 19, 2025EC Healthcare announced that they will report fiscal year 2025 results on Jun 19, 2025공고 • Nov 28EC Healthcare Declares Ordinary Interim (Semi-Annual) Dividend for the Six Months Ended 30 September 2024, Payable on 24 January 2025EC Healthcare declared Ordinary interim (semi-annual) dividend for the six months ended 30 September 2024 of HKD 0.01 per share. The dividend will be payable on 24 January 2025 with record date of 07 January 2025 and Ex-dividend date of 30 December 2024.공고 • Nov 09EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024EC Healthcare announced that they will report first half, 2025 results on Nov 28, 2024공고 • Nov 08Ec Healthcare Provides Sales Expectations for Six Months Ended 30 September 2024EC Healthcare provided sales expectations for Six months ended 30 September 2024. For the six months, The Group expects to record overall Sales Volume of no less than HKD 2,100 million for the Period, representing a decrease of no more than 4% as compared with the same period last year.공고 • Aug 16EC Healthcare Provides Group Earnings Guidance for the Period from 1 April 2024 to 30 June 2024EC Healthcare provided group earnings guidance for the period from 1 April 2024 to 30 June 2024. For the quarter, the company expects overall Sales Volume of no less than HKD 1,040 million for the Quarter, representing a decrease of no more than 4% as compared with the same quarter last year.공고 • Jun 28EC Healthcare, Annual General Meeting, Aug 23, 2024EC Healthcare, Annual General Meeting, Aug 23, 2024.공고 • Jun 15EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024EC Healthcare announced that they will report fiscal year 2024 results on Jun 27, 2024공고 • Jun 14An undisclosed buyer entered into an agreement to acquire additional 51% stake in Preeminent Medical Centre Limited from EC Healthcare (SEHK:2138) for HKD 80.2 million.An undisclosed buyer entered into an agreement to acquire additional 51% stake in Preeminent Medical Centre Limited from EC Healthcare (SEHK:2138) for HKD 80.2 million on June 12, 2024.공고 • Dec 08EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023The board of directors of EC Healthcare announced that, Mr. Wong Chi Cheung has tendered his resignation as executive director and chief digital officer of the Company with effect from 31 December 2023 due to other work commitments. Mr. Wong has confirmed that he has no disagreement with the Board and there is no other matter in relation to his resignation that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited or the holders of securities of the Company.공고 • Dec 01EC Healthcare Declares an Interim Dividend for the Six Months Ended 30 September 2023, Payable on January 19, 2024EC Healthcare declared an interim dividend of HKD 0.005 per share for the six months ended 30 September 2023. The dividend payable on January 19, 2024 to the shareholders recorded on 05 January 2024 and the Ex-dividend date is 28 December 2023.공고 • Nov 18Ec Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2023EC Healthcare provided earnings guidance for the six months ended 30 September 2023. For the period, the company expects a decrease of not more than 80% in profit after tax ("Net Profit") for the Reporting Period as compared with the Net Profit of approximately HKD 105.2 million for the corresponding period ended 30 September 2022. However, if comparing to the second half of financial year ended 31 March 2023, it is expected that the financial results of the Group may record: an increase of not less than 1,000% in Net Profit for the Reporting Period as compared with the Net Profit of approximately HKD 1.8 million for six months ended 31 March 2023. The Board believes that such year-on-year decrease in Net Profit during the Reporting Period was mainly attributable to: the decrease of approximately HKD 43.4 million in subsidies from Hong Kong Government under the Employment Support Scheme; temporary low operation leverage of the newly established service points from the previous financial year ended 31 March 2023; the increase in depreciation and amortization expenses incurred from the organic expansion during the previous financial year ended 31 March 2023; and the increase in interest expenses from bank borrowings of approximately HKD 17.0 million due the increasing interest rate.공고 • Nov 17EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023EC Healthcare announced that they will report first half, 2024 results on Nov 30, 2023공고 • Nov 02EC Healthcare Announces Executive ChangesEC Healthcare Announced that Mr. Tang Chi Fai Eddy has resigned as chief executive officer of the Company with effect from 1 November 2023 due to the wish to enable the Company to fully comply with code provision C.2.1 of the Corporate Governance Code of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, which states that the roles of chairman and chief executive should be separate and should not be performed by the same individual. Mr. Tang has confirmed that he has no disagreement with the Board and there is no matter in relation to his resignation as chief executive officer of the Company that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited or the holders of securities of the Company. Mr. Tang will continue to be the Chairman of the Board and an executive Director. Mr. Lu Lyn Wade Leslie, an executive director and the co-chief executive officer of the Company, is re-designated as the chief executive officer of the Company with effect from 1 November 2023. Mr. Lu, aged 44, joined the Group in August 2021 and is an executive director and was the co-chief executive officer of the Company. He focuses on Group's high level strategy, systems building, implementation and cultural alignment. Mr. Lu is a seasoned corporate executive with 22 years of management experience across multiple industry verticals. Mr. Lu worked in Sun Hung Kai Real Estate Agency Limited as Deputy Chief Digital Officer. Before that, Mr. Lu was an executive at Cathay Pacific Airways Limited during 2001-2007 & 2008-2020. His roles include General Manager Digital, General Manager Product, managerial positions in airline planning, cargo, flight operations, customer relationship management as well as oversea station at Thailand, Vietnam and United States. Mr. Lu graduated from The Hong Kong University of Science and Technology ("HKUST") with a Bachelor's degree in Civil Engineering in 2001 and a master's degree in Global Finance in 2009 from New York University and HKUST. Mr. Lu has entered into a service agreement with the Company on 23 August 2021 as an executive director and the co-chief executive officer of the Company for a term of 3 years commencing on 23 August 2021. A supplemental agreement has been entered into between Mr. Lu and the Company on 1 November 2023, pursuant to which Mr. Lu is re-designated as chief executive officer of the Company. Pursuant to the service agreement (as amended), the remuneration of Mr. Lu shall remain unchanged at HKD 400,000 per month plus other discretionary bonus and share options as may be determined by the Board and other terms of appointment shall also remain unchanged. His remuneration package is determined by the Board based on the recommendation of the remuneration committee of the Company, taking into account the salaries paid by comparable companies, time commitment, duties and responsibilities of Mr. Lu, the Company's performance and profitability, the remuneration policy and prevailing market rate. As at the date of this announcement, Mr. Lu holds 10,000,000 share options in the Company.공고 • Sep 02Ec Healthcare Approves Dividend for the Year Ended 31 March 2023, Payment Date Is 18 September 2023EC Healthcare on 23 August 2023 approved dividend of HKD 0.042 per share for the year ended 31 March 2023. Record date is 05 September 2023. Payment date is 18 September 2023. Ex-dividend date is 04 September 2023.공고 • Aug 24Ec Healthcare Approves Final Dividend for the Year Ended 31 March 2023EC Healthcare at its annual general meeting held on 23 August 2023 approved final dividend of HKD 0.042 per share for the year ended 31 March 2023.공고 • Jun 24+ 1 more updateEC Healthcare, Annual General Meeting, Aug 23, 2023EC Healthcare, Annual General Meeting, Aug 23, 2023.공고 • Jun 20EC Healthcare Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023EC Healthcare provided unaudited consolidated earnings guidance for the year ended 31 March 2023. For the year, company expects a decrease of not more than 61% in profit after tax, a decrease of not more than 20% in EBITDA.공고 • Jun 13EC Healthcare to Report Fiscal Year 2023 Final Results on Jun 23, 2023EC Healthcare announced that they will report fiscal year 2023 final results on Jun 23, 2023매출 및 비용 세부 내역EC Healthcare가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:UNHL.F 매출, 비용 및 순이익 (HKD Millions)날짜매출순이익일반관리비연구개발비31 Mar 254,140-167596031 Dec 244,146-89600030 Sep 244,153-12604030 Jun 244,182-15602031 Mar 244,211-19599031 Dec 234,157-11591030 Sep 234,104-4583030 Jun 233,98933572031 Mar 233,87570560031 Dec 223,62293563030 Sep 223,369117566030 Jun 223,144157496031 Mar 222,920198427031 Dec 212,823253394030 Sep 212,727309361030 Jun 212,404251342031 Mar 212,080193322031 Dec 201,854163243030 Sep 201,627133165030 Jun 201,788210191031 Mar 201,949287217031 Dec 192,023325281030 Sep 192,098364344030 Jun 191,975363361031 Mar 191,852361377031 Dec 181,715355360030 Sep 181,578348344030 Jun 181,450314322031 Mar 181,322279301031 Dec 171,253266271030 Sep 171,183253241030 Jun 171,079227214031 Mar 17975201187031 Dec 16878170169030 Sep 16780139152030 Jun 16744144137031 Mar 16708149123031 Dec 15688166122030 Sep 15668183120030 Jun 15645179116031 Mar 156211741110양질의 수익: UNHL.F 은(는) 현재 수익성이 없습니다.이익 마진 증가: UNHL.F는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: UNHL.F은 수익성이 없으며 지난 5년 동안 손실이 연평균 56.6% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 UNHL.F의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: UNHL.F은 수익성이 없어 지난 해 수익 성장률을 Consumer Services 업계(10.2%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: UNHL.F는 현재 수익성이 없으므로 자본 수익률이 음수(-5.08%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YConsumer-services 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2025/11/11 11:54종가2025/08/14 00:00수익2025/03/31연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스EC Healthcare는 7명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Zhuonan XuChina International Capital Corporation Limitednull nullChina International Capital Corporation Limitednull nullCMB International Securities Limited4명의 분석가 더 보기
공고 • Jun 17EC Healthcare to Report Fiscal Year 2026 Final Results on Jun 29, 2026EC Healthcare announced that they will report fiscal year 2026 final results at 9:30 AM, China Standard Time on Jun 29, 2026
공고 • Nov 17EC Healthcare to Report First Half, 2026 Results on Nov 28, 2025EC Healthcare announced that they will report first half, 2026 results on Nov 28, 2025
공고 • Jun 09EC Healthcare to Report Fiscal Year 2025 Results on Jun 19, 2025EC Healthcare announced that they will report fiscal year 2025 results on Jun 19, 2025
공고 • Nov 09EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024EC Healthcare announced that they will report first half, 2025 results on Nov 28, 2024
공고 • Jun 15EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024EC Healthcare announced that they will report fiscal year 2024 results on Jun 27, 2024
공고 • Nov 17EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023EC Healthcare announced that they will report first half, 2024 results on Nov 30, 2023
공고 • Jun 29EC Healthcare, Annual General Meeting, Aug 21, 2026EC Healthcare, Annual General Meeting, Aug 21, 2026.
공고 • Jun 17EC Healthcare to Report Fiscal Year 2026 Final Results on Jun 29, 2026EC Healthcare announced that they will report fiscal year 2026 final results at 9:30 AM, China Standard Time on Jun 29, 2026
공고 • Nov 28EC Healthcare Declares No Dividend for the Six Months Ended September 20, 2025EC Healthcare declared no dividend for the six months ended September 20, 2025 (2024: 1.0 HK Cents).
공고 • Nov 17EC Healthcare to Report First Half, 2026 Results on Nov 28, 2025EC Healthcare announced that they will report first half, 2026 results on Nov 28, 2025
공고 • Jun 23EC Healthcare Announces Appointment of Member of the Nomination CommitteeThe board of directors of EC Healthcare announced that Mrs. Leung Yang, Shih Ti Marianne, a non-executive director of the Company and Mr. Ma Ching Nam, an independent non-executive director of the Company, have been appointed as the members of the nomination committee under the Company with effect from 23 June 2025.
공고 • Jun 19EC Healthcare, Annual General Meeting, Aug 22, 2025EC Healthcare, Annual General Meeting, Aug 22, 2025.
공고 • Jun 09EC Healthcare to Report Fiscal Year 2025 Results on Jun 19, 2025EC Healthcare announced that they will report fiscal year 2025 results on Jun 19, 2025
공고 • Nov 28EC Healthcare Declares Ordinary Interim (Semi-Annual) Dividend for the Six Months Ended 30 September 2024, Payable on 24 January 2025EC Healthcare declared Ordinary interim (semi-annual) dividend for the six months ended 30 September 2024 of HKD 0.01 per share. The dividend will be payable on 24 January 2025 with record date of 07 January 2025 and Ex-dividend date of 30 December 2024.
공고 • Nov 09EC Healthcare to Report First Half, 2025 Results on Nov 28, 2024EC Healthcare announced that they will report first half, 2025 results on Nov 28, 2024
공고 • Nov 08Ec Healthcare Provides Sales Expectations for Six Months Ended 30 September 2024EC Healthcare provided sales expectations for Six months ended 30 September 2024. For the six months, The Group expects to record overall Sales Volume of no less than HKD 2,100 million for the Period, representing a decrease of no more than 4% as compared with the same period last year.
공고 • Aug 16EC Healthcare Provides Group Earnings Guidance for the Period from 1 April 2024 to 30 June 2024EC Healthcare provided group earnings guidance for the period from 1 April 2024 to 30 June 2024. For the quarter, the company expects overall Sales Volume of no less than HKD 1,040 million for the Quarter, representing a decrease of no more than 4% as compared with the same quarter last year.
공고 • Jun 28EC Healthcare, Annual General Meeting, Aug 23, 2024EC Healthcare, Annual General Meeting, Aug 23, 2024.
공고 • Jun 15EC Healthcare to Report Fiscal Year 2024 Results on Jun 27, 2024EC Healthcare announced that they will report fiscal year 2024 results on Jun 27, 2024
공고 • Jun 14An undisclosed buyer entered into an agreement to acquire additional 51% stake in Preeminent Medical Centre Limited from EC Healthcare (SEHK:2138) for HKD 80.2 million.An undisclosed buyer entered into an agreement to acquire additional 51% stake in Preeminent Medical Centre Limited from EC Healthcare (SEHK:2138) for HKD 80.2 million on June 12, 2024.
공고 • Dec 08EC Healthcare Announces the Resignation of Mr. Wong Chi Cheung as Executive Director and Chief Digital Officer of the Company with Effect from 31 December 2023The board of directors of EC Healthcare announced that, Mr. Wong Chi Cheung has tendered his resignation as executive director and chief digital officer of the Company with effect from 31 December 2023 due to other work commitments. Mr. Wong has confirmed that he has no disagreement with the Board and there is no other matter in relation to his resignation that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited or the holders of securities of the Company.
공고 • Dec 01EC Healthcare Declares an Interim Dividend for the Six Months Ended 30 September 2023, Payable on January 19, 2024EC Healthcare declared an interim dividend of HKD 0.005 per share for the six months ended 30 September 2023. The dividend payable on January 19, 2024 to the shareholders recorded on 05 January 2024 and the Ex-dividend date is 28 December 2023.
공고 • Nov 18Ec Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2023EC Healthcare provided earnings guidance for the six months ended 30 September 2023. For the period, the company expects a decrease of not more than 80% in profit after tax ("Net Profit") for the Reporting Period as compared with the Net Profit of approximately HKD 105.2 million for the corresponding period ended 30 September 2022. However, if comparing to the second half of financial year ended 31 March 2023, it is expected that the financial results of the Group may record: an increase of not less than 1,000% in Net Profit for the Reporting Period as compared with the Net Profit of approximately HKD 1.8 million for six months ended 31 March 2023. The Board believes that such year-on-year decrease in Net Profit during the Reporting Period was mainly attributable to: the decrease of approximately HKD 43.4 million in subsidies from Hong Kong Government under the Employment Support Scheme; temporary low operation leverage of the newly established service points from the previous financial year ended 31 March 2023; the increase in depreciation and amortization expenses incurred from the organic expansion during the previous financial year ended 31 March 2023; and the increase in interest expenses from bank borrowings of approximately HKD 17.0 million due the increasing interest rate.
공고 • Nov 17EC Healthcare to Report First Half, 2024 Results on Nov 30, 2023EC Healthcare announced that they will report first half, 2024 results on Nov 30, 2023
공고 • Nov 02EC Healthcare Announces Executive ChangesEC Healthcare Announced that Mr. Tang Chi Fai Eddy has resigned as chief executive officer of the Company with effect from 1 November 2023 due to the wish to enable the Company to fully comply with code provision C.2.1 of the Corporate Governance Code of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, which states that the roles of chairman and chief executive should be separate and should not be performed by the same individual. Mr. Tang has confirmed that he has no disagreement with the Board and there is no matter in relation to his resignation as chief executive officer of the Company that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited or the holders of securities of the Company. Mr. Tang will continue to be the Chairman of the Board and an executive Director. Mr. Lu Lyn Wade Leslie, an executive director and the co-chief executive officer of the Company, is re-designated as the chief executive officer of the Company with effect from 1 November 2023. Mr. Lu, aged 44, joined the Group in August 2021 and is an executive director and was the co-chief executive officer of the Company. He focuses on Group's high level strategy, systems building, implementation and cultural alignment. Mr. Lu is a seasoned corporate executive with 22 years of management experience across multiple industry verticals. Mr. Lu worked in Sun Hung Kai Real Estate Agency Limited as Deputy Chief Digital Officer. Before that, Mr. Lu was an executive at Cathay Pacific Airways Limited during 2001-2007 & 2008-2020. His roles include General Manager Digital, General Manager Product, managerial positions in airline planning, cargo, flight operations, customer relationship management as well as oversea station at Thailand, Vietnam and United States. Mr. Lu graduated from The Hong Kong University of Science and Technology ("HKUST") with a Bachelor's degree in Civil Engineering in 2001 and a master's degree in Global Finance in 2009 from New York University and HKUST. Mr. Lu has entered into a service agreement with the Company on 23 August 2021 as an executive director and the co-chief executive officer of the Company for a term of 3 years commencing on 23 August 2021. A supplemental agreement has been entered into between Mr. Lu and the Company on 1 November 2023, pursuant to which Mr. Lu is re-designated as chief executive officer of the Company. Pursuant to the service agreement (as amended), the remuneration of Mr. Lu shall remain unchanged at HKD 400,000 per month plus other discretionary bonus and share options as may be determined by the Board and other terms of appointment shall also remain unchanged. His remuneration package is determined by the Board based on the recommendation of the remuneration committee of the Company, taking into account the salaries paid by comparable companies, time commitment, duties and responsibilities of Mr. Lu, the Company's performance and profitability, the remuneration policy and prevailing market rate. As at the date of this announcement, Mr. Lu holds 10,000,000 share options in the Company.
공고 • Sep 02Ec Healthcare Approves Dividend for the Year Ended 31 March 2023, Payment Date Is 18 September 2023EC Healthcare on 23 August 2023 approved dividend of HKD 0.042 per share for the year ended 31 March 2023. Record date is 05 September 2023. Payment date is 18 September 2023. Ex-dividend date is 04 September 2023.
공고 • Aug 24Ec Healthcare Approves Final Dividend for the Year Ended 31 March 2023EC Healthcare at its annual general meeting held on 23 August 2023 approved final dividend of HKD 0.042 per share for the year ended 31 March 2023.
공고 • Jun 24+ 1 more updateEC Healthcare, Annual General Meeting, Aug 23, 2023EC Healthcare, Annual General Meeting, Aug 23, 2023.
공고 • Jun 20EC Healthcare Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023EC Healthcare provided unaudited consolidated earnings guidance for the year ended 31 March 2023. For the year, company expects a decrease of not more than 61% in profit after tax, a decrease of not more than 20% in EBITDA.
공고 • Jun 13EC Healthcare to Report Fiscal Year 2023 Final Results on Jun 23, 2023EC Healthcare announced that they will report fiscal year 2023 final results on Jun 23, 2023